Diagnosis and treatment of secondary lymphedema
The Coverage and Analysis Group at the Centers for Medicare and Medicaid Services (CMS) requested this technology assessment from the Technology Assessment Program (TAP) at the Agency for Healthcare Research and Quality (AHRQ). AHRQ assigned this report to the McMaster University Evidence-based Prac...
| Main Authors: | , , , |
|---|---|
| Corporate Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Rockville, Maryland
AHRQ Technology Assessment Program
2010, [2010]
|
| Series: | Technology assessment report
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The Coverage and Analysis Group at the Centers for Medicare and Medicaid Services (CMS) requested this technology assessment from the Technology Assessment Program (TAP) at the Agency for Healthcare Research and Quality (AHRQ). AHRQ assigned this report to the McMaster University Evidence-based Practice Center (MU-EPC) (Contract Number: HHSA 290-2007-10060I). The primary goals of the assessment were to examine the performance of diagnostic tests for preclinical or clinically significant secondary lymphedema, as well as to assess conservative, nonpharmacological, and nonsurgical treatments for secondary lymphedema |
|---|---|
| Item Description: | Title from PDF t.p. - "May 28, 2010.". - "Project ID: LYMT0908.". - "This publication is provided for historical reference only and the information may be out of date"--Bookshelf entry page |
| Physical Description: | 1 PDF file (various pagings) illustrations |